The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Prevalence and Incidence of Huntington's Disease: An Updated Systematic Review and Meta‐Analysis
Open accessAbstract
The incidence and prevalence of Huntington's disease (HD) based on a systematic review and meta‐analysis of 20 studies published from 1985 to 2010 was estimated at 0.38 per 100,000 person‐years (95% confidence interval [CI], 0.16–0.94) and 2.71 per 100,000 persons (95% CI, 1.55–4.72), respectively. Since 2010, there have been many new epidemiological studies of HD. We sought to update the global estimates of HD incidence and prevalence using data published up to February 2022 and perform additional analyses based on study continent. Medline and Embase were searched for epidemiological studies of HD published between 2010 and 2022. Risk of bias was assessed using a quality assessment tool. Estimated pooled prevalence or incidence was calculated using a random‐effects meta‐analysis. A total of 33 studies published between 2010 and 2022 were included. Pooled incidence was 0.48 cases per 100,000 person‐years (95% CI, 0.33–0.63). Subgroup analysis by continent demonstrated a significantly higher incidence of HD in Europe and North America than in Asia. Pooled prevalence was 4.88 per 100,000 (95% CI, 3.38–7.06). Subanalyses by continent demonstrated that the prevalence of HD was significantly higher in Europe and North America than in Africa. The minor increase in prevalence (more so than incidence) demonstrated in this updated review could relate to the enhanced availability of molecular testing, earlier diagnosis, increased life expectancy, and de novo mutations. Limitations include variable case ascertainment methods and lacking case validation data. © 2022 Her Majesty the Queen in Right of Canada. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. Reproduced with the permission of the Minister of Public Health Agency of Canada.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223 · cited 1×
“The protocol followed the standards recommended in the Preferred Reporting Items for Systematic Reviews and Meta-Analysis protocols.(14)”
MethodTrinucleotide repeat length instability and age of onset in Huntington's disease
Duyao, M., Ambrose, C., Myers, R., Novelletto, A., Persichetti, F., Frontali, M., Folstein, S., Ross, C., Franz, M., Abbott, M., et al. (1993) · Nature Genetics · doi:10.1038/ng0893-387 · Cited by 1,089
The incidence and prevalence of Huntington's disease: A systematic review and meta‐analysis
Pringsheim, T., Wiltshire, K., Day, L., Dykeman, J., Steeves, T., & Jette, N. (2012) · Movement Disorders · doi:10.1002/mds.25075 · Cited by 587
Self-citationThe Epidemiology of Guillain-Barré Syndrome Worldwide
McGrogan, A., Madle, G. C., Seaman, H. E., & de Vries, C. S. (2009) · Neuroepidemiology · doi:10.1159/000184748 · Cited by 573
The Prevalence of Huntington's Disease
Rawlins, M. D., Wexler, N. S., Wexler, A. R., Tabrizi, S. J., Douglas, I., Evans, S. J. W., & Smeeth, L. (2016) · Neuroepidemiology · doi:10.1159/000443738 · Cited by 331
Evans, S. J., Douglas, I., Rawlins, M. D., Wexler, N. S., Tabrizi, S. J., & Smeeth, L. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304636 · Cited by 207
Multisource ascertainment of Huntington disease in Canada: Prevalence and population at risk
Fisher, E. R., & Hayden, M. R. (2014) · Movement Disorders · doi:10.1002/mds.25717 · Cited by 173
Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review
Lekoubou, A., Echouffo-Tcheugui, J. B., & Kengne, A. P. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-653 · Cited by 141
The Global Prevalence of Huntington’s Disease: A Systematic Review and Discussion
Baig, S. S., Strong, M., & Quarrell, O. (2016) · Neurodegenerative Disease Management · doi:10.2217/nmt-2016-0008 · Cited by 119
Uptake of Huntington disease predictive testing in a complete population
Morrison, P., Harding-Lester, S., & Bradley, A. N. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01538.x · Cited by 108
Cited by
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Serum/glucocorticoid regulated kinase 1 (SGK1) in neurological disorders: pain or gain
Howard, P. G., Zou, P., Zhang, Y., Huang, F., Tesic, V., Wu, C. Y.-C., & Lee, R. H.-C. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114973 · Cited by 13
Danna, R., Kondle, S., Amar, O., Mabourakh, M., Chen, G., Fadol, W. B., & Mohieldin, A. M. (2025) · Biology · doi:10.3390/biology14121787 · Cited by 2
Metadata
- Authors
- Medina, A., Mahjoub, Y., Shaver, L., & Pringsheim, T.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2022-09-26
- Volume
- 37
- Issue
- 12
- Pages
- 2327-2335
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W4297229575
- Cited by
- 265
- References
- 36
- FWCI
- 7.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and Incidence of Huntington's Disease: An Updated Systematic Review and Meta‐Analysis. https://app.cochat.ai/papers/10.1002/mds.29228
- The paper
- Medina, A., Mahjoub, Y., Shaver, L., & Pringsheim, T. (2022). Prevalence and Incidence of Huntington's Disease: An Updated Systematic Review and Meta‐Analysis. Movement Disorders. https://doi.org/10.1002/mds.29228
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.